Stay updated with breaking news from Autogene Cevumeran. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A pancreatic cancer vaccine trial is now open for enrollment at the University of Cincinnati Cancer Center, the first trial of its kind in the Midwest, the university said in
Pancreatic cancer has proven resistant to immunotherapy in the past, but personalized mRNA vaccines may overcome that problem.
Pancreatic cancer has proven resistant to immunotherapy in the past, but personalized mRNA vaccines may overcome that problem.
Pancreatic cancer has proven resistant to immunotherapy in the past, but personalized mRNA vaccines may overcome that problem.
Pancreatic cancer has proven resistant to immunotherapy in the past, but personalized mRNA vaccines may overcome that problem.